Medicare to cover 2 expensive cancer drugs

[News]

Medicare confirmed on Thursday that it would continue to pay for two expensive cancer drugs that had been at the center of debate — Avastin from Genentech for breast cancer and Provenge from Dendreon for prostate cancer.

More... (http://www.news-medical.net/news/20110702/Medicare-to-cover-2-expensive-cancer-drugs.aspx)